20 April 2017 EMA/344631/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance(s): finasteride

Procedure No.: PSUSA/00001392/201608

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product full name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation

MAH of product in the member state

CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé CHIBRO-PROSCAR 5 mg, comprimé pelliculé Finasteride 1 mg Film-coated Tablets FINASTERIDE 5 mg Film-coated tablets

not available

34009 335 248 4 5

MSD FRANCE

Member State where product is authorised FR

not available

34009 379 090 7 5

MSD FRANCE

FR

not available

34009 379 091 3 6

MSD FRANCE

FR

not available

34009 335 688 4 9

MSD FRANCE

FR

not available

34009 335 249 0 6

MSD FRANCE

FR

not available

34009 335 690 9 9

MSD FRANCE

FR

not available

34009 335 689 0 0

MSD FRANCE

FR

not available

34009 335 691 5 0

MSD FRANCE

FR

UK/H/4251/001 not available

PL 00289/0826 PA 1286/44/1

UK IE

Finasteride 5 mg film-coated tablets Finasteride 5 mg Tablets Finasteride AHCL 1 mg compresse rivestite con film FINASTID 5 mg compresse rivestite con film FINASTID 5 mg compresse rivestite con film GENAPROST 5 mg compresse rivestite con film GENAPROST 5 mg compresse rivestite con film PILUS 1 mg compressa rivestita con film PILUS 1 mg compressa rivestita con film PILUS 1 mg compressa rivestita con film

not available AT/H/0268/001 NL/H/1149/001

PL 21880/0052 PL 04416/0816 039595196

not available

028309019

not available

028309021

not available

028371019

not available

028371021

not available

034824019

not available

034824033

not available

034824045

TEVA UK LIMITED MERCK SHARP & DOHME IRELAND (HUMAN HEALTH) LTD MEDREICH PLC SANDOZ LTD ACCORD HEALTHCARE LIMITED NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L.

List of nationally authorised medicinal products EMA/344631/2017

UK UK IT IT IT IT IT IT IT IT

Page 2/6

Product full name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation

MAH of product in the member state

PILUS 1 mg compressa rivestita con film PILUS 1 mg compressa rivestita con film PROPECIA 1 mg compresse rivestite con film PROPECIA 1 mg compresse rivestite con film PROPECIA 1 mg compresse rivestite con film PROPECIA 1 mg compresse rivestite con film PROPECIA 1 mg compresse rivestite con film PROPECIA 1 mg comprimate filmate

not available

034824058

not available

034824021

SE/H/0158/001

034237014

NEOPHARMED GENTILI S.R.L. NEOPHARMED GENTILI S.R.L. MSD ITALIA S.R.L.

SE/H/0158/001

034237038

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237040

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237053

MSD ITALIA S.R.L.

IT

SE/H/0158/001

034237026

MSD ITALIA S.R.L.

IT

not available

5198/2005/01

& DOHME

RO

PROPECIA 1 mg comprimate filmate

not available

5198/2005/01

& DOHME

RO

Propecia 1 mg comprimidos recubiertos con película PROPECIA 1 mg comprimidos revestidos por película PROPECIA 1 mg comprimidos revestidos por película PROPECIA 1 mg comprimidos revestidos por película PROPECIA 1 mg comprimidos revestidos por película PROPECIA 1 mg comprimidos revestidos por película PROPECIA 1 mg Film-Coated Tablets

SE/H/0158/001

62.441

& DOHME DE

ES

SE/H/0158/001

2832988

& DOHME,

PT

SE/H/0158/001

2832780

& DOHME,

PT

SE/H/0158/001

2832889

& DOHME,

PT

SE/H/0158/001

2832582

& DOHME,

PT

SE/H/0158/001

2832681

& DOHME,

PT

not available

MA058/00801

& DOHME

MT

PROPECIA 1 mg Film-Coated Tablets

not available

MA058/00801

& DOHME

MT

PROPECIA 1 mg filmdragerad tablett Propecia 1 mg filmdragerade tabletter

SE/H/0158/001 SE/H/0158/001

13483 13713

MERCK SHARP ROMANIA SRL MERCK SHARP ROMANIA SRL MERCK SHARP ESPAÑA, S.A MERCK SHARP LDA. MERCK SHARP LDA. MERCK SHARP LDA. MERCK SHARP LDA. MERCK SHARP LDA. MERCK SHARP LTD. MERCK SHARP LTD. MERCK SHARP MERCK SHARP

& DOHME BV & DOHME BV

SE FI

List of nationally authorised medicinal products EMA/382341/2015

Member State where product is authorised IT IT IT

Page 3/6

Product full name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation

MAH of product in the member state

PROPECIA 1 mg filmomhulde tabletten Propecia 1 mg filmsko obložene tablete

SE/H/0158/001 not available

RVG 27397 H/99/01294/001

Propecia 1 mg filmsko obložene tablete

not available

H/99/01294/001

Propecia 1 mg Filmtabletten

SE/H/0158/001

1-24532

Propecia 1 mg filmuhúðaðar töflur Propecia 1 mg tabletti, kalvopäällysteinen PROPECIA 1 mg, comprimé pelliculé PROPECIA 1 mg, comprimé pelliculé PROPECIA 1 mg, comprimé pelliculé PROPECIA 1 mg, comprimé pelliculé PROPECIA 1 mg, comprimé pelliculé PROPECIA 1 mg, film-coated tablets PROPECIA 1 mg, film-coated tablets PROPECIA 1 mg, tabletki powlekane PROPECIA 1 mg, tabletki powlekane PROPECIA 1mg, επικαλυμμένα με λεπτό υμένιο δισκία Propecia, filmovertrukne tabletter PROPECIA® 1 mg Film-Coated Tablets

SE/H/0158/001 SE/H/0158/001

IS/1/02/010/01 13713

MERCK SHARP & DOHME BV MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O. MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O. MERCK SHARP & DOHME GES.M.B.H. MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV

SE/H/0158/001 SE/H/0158/001 SE/H/0158/001 SE/H/0158/001 SE/H/0158/001 not available not available not available not available SE/H/158/01/R02

34009 349 065 4 1 34009 349 070 8 1 34009 349 066 0 2 34009 349 068 3 1 34009 349 067 7 0 18318 18318 4602 4602 52369/30-06-2016

MSD FRANCE MSD FRANCE MSD FRANCE MSD FRANCE MSD FRANCE MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MSD POLSKA SP. Z O.O. MSD POLSKA SP. Z O.O. VIANEX S.A.

FR FR FR FR FR CY CY PL PL GR

SE/H/0158/001 not available

30252 PL 0025/0351

DK UK

PROPECIA® 1 mg Film-Coated Tablets

not available

PL 0025/0351

PROPECIA® 1 mg Filmtabletten

SE/H/0158/001

44270.00.00

PROPECIA® 1 mg, comprimé pelliculé PROPECIA® potahované tablety PROPECIA® potahované tablety PROSCAR 5 mg compresse rivestite con film

SE/H/0158/001 not available not available not available

2009030231 87/244/99-C 87/244/99-C 028308017

MERCK SHARP & DOHME BV MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MSD SHARP & DOHME GMBH MSD BELGIUM BVBA/SPRL MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MERCK SHARP & DOHME LTD.

List of nationally authorised medicinal products EMA/382341/2015

Member State where product is authorised NL SI SI AT IS FI

UK DE LU CZ CZ IT

Page 4/6

Product full name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation

MAH of product in the member state

PROSCAR 5 mg compresse rivestite con film PROSCAR 5 mg comprimate filmate

not available

028308029

not available

5885/2013/01

PROSCAR 5 mg comprimate filmate

not available

5885/2013/02

PROSCAR 5 mg comprimidos recubiertos con película PROSCAR 5 mg comprimidos revestidos por película PROSCAR 5 mg comprimidos revestidos por película PROSCAR 5 mg comprimidos revestidos por película PROSCAR 5 mg comprimidos revestidos por película PROSCAR 5 mg comprimidos revestidos por película PROSCAR 5 mg comprimidos revestidos por película Proscar 5 mg filmdragerad tablett Proscar 5 mg filmdragerade tabletter Proscar 5 mg Filmtabletten

not available

59.830

not available

2133189

not available

2133288

not available

2133387

not available

2133189

not available

2133288

not available

2133387

not available not available not available

11644 10751 1-19689

Proscar 5 mg tabletter PROSCAR 5 mg tabletti, kalvopäällysteinen PROSCAR 5 mg, filmomhulde tabletten PROSCAR επικαλυμμένο με λεπτό υμένιο δισκίο 5 mg/TAB PROSCAR, 5 mg, film-coated tablets PROSCAR, 5 mg, tabletki powlekane Proscar, filmovertrukne tabletter PROSCAR® 5 mg filmom obložene tablete

not available not available

7841 10751

MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME ROMANIA SRL MERCK SHARP & DOHME ROMANIA SRL LABORATORIOS CHIBRET, S.A. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME, LDA. MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV MERCK SHARP & DOHME GES.M.B.H. MERCK SHARP & DOHME BV MERCK SHARP & DOHME BV

not available not available

RVG 15482 21729

MERCK SHARP & DOHME BV VIANEX S.A.

NL GR

not not not not

19539 R/3621 14514 HR-H-039526411

MERCK SHARP & DOHME BV MSD POLSKA SP. Z O.O. MERCK SHARP & DOHME BV MERCK SHARP & DOHME D.O.O.

CY PL DK HR

List of nationally authorised medicinal products EMA/382341/2015

available available available available

Member State where product is authorised IT RO RO ES PT PT PT PT PT PT SE FI AT NO FI

Page 5/6

Product full name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation

MAH of product in the member state

PROSCAR® 5 mg, comprimés pelliculés PROSCAR® 5 mg, comprimés pelliculés PROSCAR® 5 mg, filmomhulde tabletten PROSCAR® 5 mg, Filmtabletten PROSCAR® 5 mg film-coated Tablets (finasteride) PROSCAR® 5 mg film-coated Tablets (finasteride) PROSCAR° 5 mg Filmtabletten

not available

BE160124

MSD BELGIUM BVBA/SPRL

Member State where product is authorised BE

not available

2003107721

MSD BELGIUM BVBA/SPRL

LU

not available

BE160124

MSD BELGIUM BVBA/SPRL

BE

not available not available

BE160124 MA 058/00701

BE MT

not available

PL 0025/0279

not available

42859.00.00

PROSTIDE 5 mg compresse rivestite con film

not available

028356018

PROSTIDE 5 mg compresse rivestite con film

not available

028356020

Prostide 5 mg filmsko obložene tablete

not available

H/97/01301/001

Prostide 5 mg filmsko obložene tablete

not available

H/97/01301/001

MSD BELGIUM BVBA/SPRL MERCK SHARP & DOHME LTD. MERCK SHARP & DOHME LTD. MSD SHARP & DOHME GMBH SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O. MERCK SHARP & DOHME INOVATIVNA ZDRAVILA D.O.O.

List of nationally authorised medicinal products EMA/382341/2015

UK DE IT IT SI SI

Page 6/6

Finasteride - European Medicines Agency - Europa EU

Apr 20, 2017 - Send a question via our website www.ema.europa.eu/contact ... Product full name ... FINASTERIDE 5 mg Film-coated tablets not available.

127KB Sizes 30 Downloads 217 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...